# A Study of E7070 in Patients With Gastric Cancer

> **NCT00165594** · PHASE1,PHASE2 · TERMINATED · sponsor: **Eisai Co., Ltd.** · enrollment: 50 (—)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** E7070

## Key facts

- **NCT ID:** NCT00165594
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-02
- **Primary completion:** 2006-07
- **Final completion:** 2006-08
- **Target enrollment:** 50 (—)
- **Why stopped:** Study was completed.
- **Last updated:** 2014-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00165594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00165594, "A Study of E7070 in Patients With Gastric Cancer". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00165594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*